Hormone Receptor-Positive and HER2-Negative Advanced Breast Cancer
1 clinical trials · Condition
◉ Watch Hormone Receptor-Positive and HER2-Negative Advanced Breast Cancer
| Record | Firm | Date |
|---|---|---|
| Comparing Endocrine Therapy Combined With High-Dose Palbociclib and Hydroxychloroquine to Endocrine Therapy Combined With Standard-Dose Palbociclib for Hormone Receptor-Positive and HER2-Negative Advanced Breast Cancer (NCT07061717) | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 2025-07-01 |
Track Hormone Receptor-Positive and HER2-Negative Advanced Breast Cancer automatically
Every clearance here is in the API, with alerts when new ones post.